Travere Therapeutics Inc (NASDAQ:TVTX)

Delayed Data
As of 4:00pm ET
 +0.96 / +3.46%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Travere Therapeutics Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 20.00. The median estimate represents a +28.79% increase from the last price of 28.73.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Travere Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.82%
Growthannually 22.26%


Growthquarterly -16.56%
Growthannually 13.37%
Key to the earnings and sales forecast charts.